Ceren Uyar-Boztaş

Ceren Uyar-Boztaş

Auto-generated profile, based on publicly available information

Ceren Uyar-Boztaş


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
AMAyhanım Elif MÜDERRİSOĞLU
Ayhanım Elif MÜDERRİSOĞLU
Betul Rabia ERDOGANBetul Rabia ERDOGAN
Betul Rabia ERDOGAN
ZYZeynep Elif Yeşilyurt-Dirican
Zeynep Elif Yeşilyurt-Dirican
CUCeren Uyar-Boztaş
Ceren Uyar-Boztaş
IKIrem Karaomerlioglu
Irem Karaomerlioglu
EIebru arioglu inan
ebru arioglu inan
Dipeptidyl peptidase-4 (DPP4) inhibitors, a class of oral antidiabetic drugs, have been shown to be protective on the vascular system because of their antiinflammatory, antiatherosclerotic and vasodilatory effects. ß2-adrenoceptors (ß2-ARs) mediate the vasorelaxation in the aorta. However, ß3-adrenoceptor-mediated relaxation has not been studied in diabetic aorta yet. Thus, we aimed to study the effect of sitagliptin treatment on ß2- and ß3-adrenoceptor-mediated relaxations in the diabetic rat aorta. 8-week old Sprague Dawley rats were divided into three groups; control, diabetic, sitagliptin treated diabetic. Diabetes was induced by injection of streptozotocin (35 or 40 mg/kg, intraperitoneally). After 10 weeks of diabetes, some of the diabetic rats were treated with sitagliptin (orally, 10mg/kg/day). ß2- and ß3-AR-mediated relaxation responses were evaluated by using isoprenaline and CL316,243, respectively. ß3-AR-mediated relaxation experiments were repeated in presence of L-NAME. Western blotting and immunohistochemistry were done to determine the abundance of ß3-adrenoceptor and endothelial nitric oxide synthase (eNOS). Isoprenaline-mediated relaxation response was impaired in the diabetic group and sitagliptin treatment did not improve it. There was no significant change in CL316,243 mediated-relaxation or protein expression of ß3-ARs among the groups. However, the ratio of phosphorylated eNOS/NOS protein was increased markedly in sitagliptin treated group which points the stimulating effect of this drug on the eNOS pathway. Our results indicate that sitagliptin treatment does not alter ß-AR-mediated relaxation in streptozotocin-diabetic rat aorta, however it significantly stimulates the eNOS pathway. Future studies are needed to clarify the relationship between the eNOS pathway and DPP-4 inhibition.